^
CANCER:
Small Intestinal Carcinoma
PTEN mutation + MSI-H/dMMR
Small Intestinal Carcinoma
PD1 inhibitor
Resistant
:
C3
Clin Cancer Res - 1wk
dMMR/MSI-H + TMB-L
Small Intestinal Carcinoma
PD1 inhibitor
Resistant
:
C3
Clin Cancer Res - 1wk
NTRK3 fusion
Small Intestinal Carcinoma
entrectinib
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
gemcitabine + docetaxel
Sensitive
:
A2
NTRK1 fusion
Small Intestinal Carcinoma
entrectinib
Sensitive
:
A2
NTRK2 fusion
Small Intestinal Carcinoma
entrectinib
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
LV5FU2
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
nivolumab
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
pembrolizumab + ipilimumab
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
FOLFOX
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
CAPOX
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
bevacizumab
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
capecitabine
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
5-fluorouracil
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
irinotecan
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
FOLFIRI
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
docetaxel
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
paclitaxel
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
paclitaxel + gemcitabine
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
carboplatin + paclitaxel
Sensitive
:
A2
NTRK1 fusion
Small Intestinal Carcinoma
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Small Intestinal Carcinoma
larotrectinib
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our